移动医疗在改善印度镰状细胞病管理方面的潜力。
The Potential of mHealth as a Game Changer for the Management of Sickle Cell Disease in India.
机构信息
ICMR-National Institute of Research in Tribal Health, Jabalpur, India.
出版信息
JMIR Mhealth Uhealth. 2021 Apr 13;9(4):e25496. doi: 10.2196/25496.
Sickle cell disease (SCD) is a chronic genetic disease that requires lifelong therapy and monitoring. Low drug adherence and poor monitoring may lead to an increase in morbidities and low quality of life. In the era of digital technology, various mobile health (mHealth) apps are being tested for their potential in increasing drug adherence in patients with SCD. We herewith discuss the applicability and feasibility of these mHealth apps for the management of SCD in India.
镰状细胞病（SCD）是一种慢性遗传性疾病，需要终身治疗和监测。药物依从性低和监测不良可能导致发病率增加和生活质量下降。在数字技术时代，各种移动医疗（mHealth）应用程序正在测试其提高 SCD 患者药物依从性的潜力。我们在此讨论这些 mHealth 应用程序在印度管理 SCD 的适用性和可行性。
Zotero 插件